Rheumatoid Arthritis

Latest News

The drug is indicated for imultiple diseases, such as rheumatoid arthritis (RA), giant cell arteritis, polyarticular juvenile idiopathic arthritis, systemic juvenile idiopathic arthritis, and COVID-19.| Pawel | stock.adobe.com
FDA Approves Tocilizumab-Anoh as a Biosimilar to Actemra

January 31st 2025

The approval includes indications for rheumatoid arthritis, giant cell arteritis, polyarticular juvenile idiopathic arthritis, systemic juvenile idiopathic arthritis, and COVID-19.

Woman hand suffering from joint pain with gout in finger - Image credit: doucefleur | stock.adobe.com
SEL-212 Shows Promise in Treating Chronic Refractory Gout with High Response Rates

January 22nd 2025

Rheumatoid Arthritis, Obesity, BMI, Therapy | Image Credit: © yodiyim | stock.adobe.com
Higher BMI Associated With Risk of Discontinuation for Non–TNF-Targeted Therapy for Rheumatoid Arthritis

January 14th 2025

FDA Grants Rare Pediatric Disease Designation to Small Molecule for Systemic Juvenile Idiopathic Arthritis
FDA Grants Rare Pediatric Disease Designation to Small Molecule for Systemic Juvenile Idiopathic Arthritis

December 5th 2024

Biosimilar Etanercept | Image Credit: Evrymmnt - stock.adobe.com
Study: Biosimilar Etanercept Shows Equivalence With Reference Product for Rheumatoid Arthritis

August 21st 2024

Video Interviews

More News